Annual EBIT
$1.16 M
-$9.86 M-89.50%
31 December 2023
Summary:
GoodRx Holdings annual earnings before interest & taxes is currently $1.16 million, with the most recent change of -$9.86 million (-89.50%) on 31 December 2023. During the last 3 years, it has risen by +$276.69 million (+100.42%). GDRX annual EBIT is now -99.13% below its all-time high of $146.12 million.GDRX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
$20.47 M
-$5.75 M-21.92%
30 September 2024
Summary:
GoodRx Holdings quarterly earnings before interest & taxes is currently $20.47 million, with the most recent change of -$5.75 million (-21.92%) on 30 September 2024. Over the past year, it has increased by +$52.35 million (+164.20%). GDRX quarterly EBIT is now -53.22% below its all-time high of $43.75 million, reached on 31 March 2020.GDRX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$51.80 M
+$52.35 M+9570.02%
30 September 2024
Summary:
GoodRx Holdings TTM earnings before interest & taxes is currently $51.80 million, with the most recent change of +$52.35 million (+9570.02%) on 30 September 2024. Over the past year, it has increased by +$33.65 million (+185.37%). GDRX TTM EBIT is now -65.86% below its all-time high of $151.72 million, reached on 30 June 2020.GDRX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDRX EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.5% | +164.2% | +185.4% |
| 3 y3 years | +100.4% | +191.9% | +117.4% |
| 5 y5 years | -98.5% | -46.3% | +35.9% |
GDRX EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -91.4% | +100.4% | -21.9% | +164.2% | at high | +117.4% |
| 5 y | 5 years | -99.1% | +100.4% | -53.2% | +106.8% | -65.9% | +114.1% |
| alltime | all time | -99.1% | +100.4% | -53.2% | +106.8% | -65.9% | +114.1% |
GoodRx Holdings EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.47 M(-21.9%) | $51.80 M(-9570.0%) |
| June 2024 | - | $26.21 M(+75.5%) | -$547.00 K(-14.1%) |
| Mar 2024 | - | $14.94 M(-252.2%) | -$637.00 K(-155.1%) |
| Dec 2023 | $1.16 M(-89.5%) | -$9.81 M(-69.2%) | $1.16 M(-93.6%) |
| Sept 2023 | - | -$31.88 M(-222.0%) | $18.15 M(-51.3%) |
| June 2023 | - | $26.12 M(+56.1%) | $37.24 M(+369.7%) |
| Mar 2023 | - | $16.73 M(+132.9%) | $7.93 M(-28.0%) |
| Dec 2022 | $11.01 M(-18.2%) | $7.18 M(-156.1%) | $11.01 M(-29.4%) |
| Sept 2022 | - | -$12.79 M(+301.0%) | $15.60 M(-55.9%) |
| June 2022 | - | -$3.19 M(-116.1%) | $35.41 M(-7.5%) |
| Mar 2022 | - | $19.81 M(+68.3%) | $38.26 M(+184.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $13.46 M(-104.9%) | $11.77 M(+67.9%) | $13.46 M(-104.5%) |
| Sept 2021 | - | $7.01 M(-2174.6%) | -$297.73 M(-18.7%) |
| June 2021 | - | -$338.00 K(-93.2%) | -$366.40 M(+13.0%) |
| Mar 2021 | - | -$4.98 M(-98.3%) | -$324.27 M(+17.7%) |
| Dec 2020 | -$275.54 M(-307.9%) | -$299.42 M(+385.6%) | -$275.54 M(-630.5%) |
| Sept 2020 | - | -$61.66 M(-247.5%) | $51.94 M(-65.8%) |
| June 2020 | - | $41.79 M(-4.5%) | $151.72 M(+38.0%) |
| Mar 2020 | - | $43.75 M(+55.9%) | $109.92 M(+66.1%) |
| Dec 2019 | $132.55 M(+77.8%) | $28.05 M(-26.4%) | $66.17 M(+73.6%) |
| Sept 2019 | - | $38.12 M | $38.12 M |
| Dec 2018 | $74.54 M | - | - |
FAQ
- What is GoodRx Holdings annual earnings before interest & taxes?
- What is the all time high annual EBIT for GoodRx Holdings?
- What is GoodRx Holdings annual EBIT year-on-year change?
- What is GoodRx Holdings quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for GoodRx Holdings?
- What is GoodRx Holdings quarterly EBIT year-on-year change?
- What is GoodRx Holdings TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for GoodRx Holdings?
- What is GoodRx Holdings TTM EBIT year-on-year change?
What is GoodRx Holdings annual earnings before interest & taxes?
The current annual EBIT of GDRX is $1.16 M
What is the all time high annual EBIT for GoodRx Holdings?
GoodRx Holdings all-time high annual earnings before interest & taxes is $146.12 M
What is GoodRx Holdings annual EBIT year-on-year change?
Over the past year, GDRX annual earnings before interest & taxes has changed by -$9.86 M (-89.50%)
What is GoodRx Holdings quarterly earnings before interest & taxes?
The current quarterly EBIT of GDRX is $20.47 M
What is the all time high quarterly EBIT for GoodRx Holdings?
GoodRx Holdings all-time high quarterly earnings before interest & taxes is $43.75 M
What is GoodRx Holdings quarterly EBIT year-on-year change?
Over the past year, GDRX quarterly earnings before interest & taxes has changed by +$52.35 M (+164.20%)
What is GoodRx Holdings TTM earnings before interest & taxes?
The current TTM EBIT of GDRX is $51.80 M
What is the all time high TTM EBIT for GoodRx Holdings?
GoodRx Holdings all-time high TTM earnings before interest & taxes is $151.72 M
What is GoodRx Holdings TTM EBIT year-on-year change?
Over the past year, GDRX TTM earnings before interest & taxes has changed by +$33.65 M (+185.37%)